Corpus Intelligence IC Memo — BAPTIST MEM HOSPITAL GOLDEN TRIANGLE 2026-04-26 05:02 UTC
IC Memo — BAPTIST MEM HOSPITAL GOLDEN TRIANGLE
Investment Committee Memorandum | MS | 154 beds | Grade C | EBITDA uplift $16.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAPTIST MEM HOSPITAL GOLDEN TRIANGLE

CCN 250100 | LOWNDES, MS | 154 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BAPTIST MEM HOSPITAL GOLDEN TRIANGLE is a 154-bed suburban community hospital in LOWNDES, MS with $221.1M in net patient revenue and a 6.9% operating margin. The hospital serves a payer mix of 43.9% Medicare, 6.6% Medicaid, and 49.5% commercial.

Thesis: Turnaround. Our ML models identify $16.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.9% to 14.3% (+736bps).

Net Revenue HCRIS$221.1M
Current EBITDA COMPUTED$15.3M
Operating Margin COMPUTED6.9%
Occupancy HCRIS53.7%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS22.6%
Distress Probability ML47.6%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
29
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 6.9% places it above the state median. Among 29 size-comparable peers (77-308 beds), the median margin is -4.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (77-308), prioritizing same-state peers. 29 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAPTIST MEM HOSPITAL GOLDEN TR (Target)MS154$221.1M6.9%
MEMORIAL HOSPITAL AT GULFPORTMS278$700.2M-15.7%
SINGING RIVER HEALTH SYSTEMMS294$415.9M-12.8%
BAPTIST MEM HOSPITAL DESOTOMS298$301.6M-5.2%
BAPTIST MEM HOSPITAL NORTH MISMS195$229.4M0.7%
JEFF ANDERSON REGIONAL MEDICALMS270$213.3M-25.9%
MAGNOLIA HOSPITALMS158$161.6M-4.7%
SOUTH CENTRAL REGIONAL MEDICALMS268$146.9M-1.3%
CENTRAL MISSISSIPPI MEDICAL CEMS226$142.2M-12.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.6M+210bp18mo
Cost to Collect4.5%2.5%$4.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.7M+122bp9mo
Clean Claim Rate88.0%96.0%$141K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.6M
Cost to Collect
$4.4M
Denial Rate Reduction
$4.4M
A/R Days Reduction
$2.7M
Clean Claim Rate
$141K
Total EBITDA Uplift$16.3M
Current EBITDA$15.3M
+ RCM Uplift+$16.3M
Pro Forma EBITDA$31.6M
Current Margin6.9%
Pro Forma Margin14.3%
WC Released (1x)$8.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$23.6M$263.9M11.18x62.1%
Base (11x exit)10.0x11.0x$23.6M$298.0M12.63x66.1%
Bull Case9.0x11.0x$21.2M$359.3M16.92x76.1%
Bull (12x exit)9.0x12.0x$21.2M$398.3M18.75x79.7%
Bear Case11.0x10.0x$26.0M$174.9M6.74x46.5%
Bear (11x exit)11.0x11.0x$26.0M$200.8M7.74x50.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 29 hospitals with 77-308 beds
  • Same-state prioritization (n=30)
  • Comp margins: P25=-15.7% / P50=-4.7% / P75=1.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.